Envista (NVST) vs Warby Parker (WRBY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Envista (NVST) has outperformed Warby Parker (WRBY) over the past year, gaining 10.4% versus a gain of 1.4%. Over five years, NVST leads with a -41.3% price change compared with -54.4% for WRBY. Envista is the larger company by market cap ($3.65 billion vs $3.08 billion), about 1.2 times the size, while Warby Parker is growing revenue faster (+13.0% vs +8.3%).
On valuation, Envista trades at a lower forward P/E (13.7x vs 40.6x for Warby Parker). Envista converts more of its revenue into profit, with a net margin of 1.7% versus 0.2%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NVST | WRBY |
|---|---|---|
| Share price | $22.72 | $24.95 |
| Market cap | $3.65B | $3.08B |
| 1-day change | -1.39% | -1.42% |
| YTD return | +4.65% | +14.50% |
| 1-year return | +10.40% | +1.42% |
| 5-year return | -41.32% | -54.43% |
| P/E ratio (TTM) | 39.17 | 415.83 |
| Forward P/E | 13.65 | 40.58 |
| EPS (TTM) | $0.58 | $0.06 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $2.72B | $871.90M |
| Revenue growth (YoY) | +8.32% | +13.04% |
| Net income (latest FY) | $47.00M | $1.64M |
| Gross margin | 54.67% | 53.97% |
| Operating margin | 7.95% | -0.61% |
| Net margin | 1.73% | 0.19% |
| 52-week high | $30.42 | $31.00 |
| 52-week low | $18.77 | $14.96 |
| Distance from 52-week high | -25.31% | -19.52% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +30.68% | +22.08% |
| Average volume | 2.77M | 2.85M |
| Shares outstanding | 160.62M | 108.24M |
| Employees | 12,000 | 2,275 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Ophthalmic Goods |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Warby Parker trades at a higher earnings multiple (415.8x vs 39.2x trailing P/E).
About Envista
NVST stock →Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables.
Health Care · Medical/Dental Instruments · 12,000 employees
About Warby Parker
WRBY stock →Warby Parker Inc. sells eyewear products through its retail and e-commerce platform in the United States and Canada.
Health Care · Ophthalmic Goods · 2,275 employees
NVST vs WRBY FAQ
Which is bigger, Envista or Warby Parker?
Envista (NVST) is larger, with a market capitalization of $3.65B compared with $3.08B for Warby Parker (WRBY).
Which stock has performed better over the past year, NVST or WRBY?
NVST returned +10.40% over the past 12 months, compared with +1.42% for WRBY (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, NVST or WRBY?
NVST has the lower trailing P/E at 39.2, versus 415.8 for WRBY. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Envista and Warby Parker in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Dental Instruments for Envista and Ophthalmic Goods for Warby Parker.